Arcutis Biotherapeutics (ARQT) Prepaid Assets (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Prepaid Assets of $32.0 million for Q1 2026, up 39.43% year-over-year from $22.9 million in Q1 2025, and up 51.71% quarter-over-quarter from $21.1 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Prepaid Assets (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $32.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 39.43% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at $32.0 million (up 39.43% YoY), while the FY2025 annual figure was $21.1 million, up 7.24% from the prior year.
- Prepaid Assets for Q1 2026 stood at $32.0 million, up from $21.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $32.0 million in Q1 2026, with the low at $10.6 million in Q4 2022.
- The 5-year median for Prepaid Assets is $18.4 million (2024), against an average of $17.2 million.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets decreased 27.8% in 2022, then soared 76.27% in 2023.
- Arcutis Biotherapeutics' Prepaid Assets stood at $10.6 million in 2022, then jumped by 76.27% to $18.7 million in 2023, then rose by 5.09% to $19.7 million in 2024, then rose by 7.24% to $21.1 million in 2025, then soared by 51.71% to $32.0 million in 2026.
- Business Quant data shows ARQT's Prepaid Assets at $32.0 million in Q1 2026, $21.1 million in Q4 2025, and $20.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.77 Mn |
| Mar 31, 2026 | 31.98 Mn |
| Dec 31, 2025 | 21.08 Mn |
| Sep 30, 2025 | 20.31 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Mar 31, 2025 | 22.94 Mn |
| Dec 31, 2024 | 19.66 Mn |
| Sep 30, 2024 | 18.41 Mn |
| Jun 30, 2024 | 14.25 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Dec 31, 2023 | 18.70 Mn |
| Sep 30, 2023 | 20.18 Mn |
| Jun 30, 2023 | 11.59 Mn |
| Mar 31, 2023 | 13.03 Mn |
| Dec 31, 2022 | 10.61 Mn |
| Sep 30, 2022 | 11.78 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Sep 30, 2021 | 12.96 Mn |